Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Insights from Scale-up frontrunners | Mickel Jansen (dsm-firmenich)
Mickel Jansen, Principal Scientist BioProcess Development of dsm-firmenich, shares last year’s improvements and reflects on scaling, innovation, and keeping the end in mind.
Fenneke Jolink
One year later: Insights from Scale-up frontrunners | Robyn Eijlander (NIZO)
Robyn Eijlander, Science Innovation Manager and Program Manager at NIZO and BFF, shares last year’s improvements and shows off a nice bracelet.
Fenneke Jolink
Expanding our community: Meet the newest Planet B.io residents
After the summer break, Planet B.io welcomed several new residents. Each brings valuable expertise and innovation, further strengthening our growing ecosystem. Below, you will find a short introduction to the companies that have recently joined us at the Biotech Campus Delft.